Candon S - Search Results

1

Have serological tests changed the face of childhood coeliac disease? A retrospective cohort study.

Garnier-Lengliné H, Brousse N, Candon S, Goulet O, Ruemmele FM, Schmitz J. Garnier-Lengliné H, et al. Among authors: candon s. BMJ Open. 2012 Nov 22;2(6):e001385. doi: 10.1136/bmjopen-2012-001385. Print 2012. BMJ Open. 2012. PMID: 23180388 Free PMC article.

2

Clinical and biological consequences of immunization to infliximab in pediatric Crohn's disease.

Candon S, Mosca A, Ruemmele F, Goulet O, Chatenoud L, Cézard JP. Candon S, et al. Clin Immunol. 2006 Jan;118(1):11-9. doi: 10.1016/j.clim.2005.07.010. Epub 2005 Aug 25. Clin Immunol. 2006. PMID: 16125467

3

Dramatic clinical efficacy of cladribine in Rosai-Dorfman disease and evolution of the cytokine profile: towards a new therapeutic approach.

Aouba A, Terrier B, Vasiliu V, Candon S, Brousse N, Varet B, Hermine O. Aouba A, et al. Among authors: candon s. Haematologica. 2006 Dec;91(12 Suppl):ECR52. Haematologica. 2006. PMID: 17194658

4

12-month follow-up after successful infliximab therapy in pediatric crohn disease.

Wynands J, Belbouab R, Candon S, Talbotec C, Mougenot JF, Chatenoud L, Schmitz J, Cézard JP, Goulet O, Hugot JP, Ruemmele FM. Wynands J, et al. Among authors: candon s. J Pediatr Gastroenterol Nutr. 2008 Mar;46(3):293-8. doi: 10.1097/MPG.0b013e31815604cd. J Pediatr Gastroenterol Nutr. 2008. PMID: 18376247

5

Monitoring of anti-transglutaminase autoantibodies in pediatric celiac disease using a sensitive radiobinding assay.

Candon S, Mauvais FX, Garnier-Lengliné H, Chatenoud L, Schmitz J. Candon S, et al. J Pediatr Gastroenterol Nutr. 2012 Mar;54(3):392-6. doi: 10.1097/MPG.0b013e318232c459. J Pediatr Gastroenterol Nutr. 2012. PMID: 21900830

6

A soluble form of IL-27Rα is a natural IL-27 antagonist.

Dietrich C, Candon S, Ruemmele FM, Devergne O. Dietrich C, et al. Among authors: candon s. J Immunol. 2014 Jun 1;192(11):5382-9. doi: 10.4049/jimmunol.1303435. Epub 2014 Apr 25. J Immunol. 2014. PMID: 24771852 Clinical Trial.

7

Trough Levels of Infliximab at Week 6 Are Predictive of Remission at Week 14 in Pediatric Crohn's Disease.

Courbette O, Aupiais C, Viala J, Hugot JP, Roblin X, Candon S, Louveau B, Chatenoud L, Martinez-Vinson C. Courbette O, et al. Among authors: candon s. J Pediatr Gastroenterol Nutr. 2020 Mar;70(3):310-317. doi: 10.1097/MPG.0000000000002536. J Pediatr Gastroenterol Nutr. 2020. PMID: 31651668

8

Rituximab in severe lupus nephritis: early B-cell depletion affects long-term renal outcome.

Melander C, Sallée M, Trolliet P, Candon S, Belenfant X, Daugas E, Rémy P, Zarrouk V, Pillebout E, Jacquot C, Boffa JJ, Karras A, Masse V, Lesavre P, Elie C, Brocheriou I, Knebelmann B, Noël LH, Fakhouri F. Melander C, et al. Among authors: candon s. Clin J Am Soc Nephrol. 2009 Mar;4(3):579-87. doi: 10.2215/CJN.04030808. Epub 2009 Mar 4. Clin J Am Soc Nephrol. 2009. PMID: 19261822 Free PMC article.

9

Incidence of infectious complications in highly sensitized renal transplant recipients treated by rituximab: a case-controlled study.

Scemla A, Loupy A, Candon S, Mamzer MF, Martinez F, Zuber J, Sberro R, Legendre C, Thervet E. Scemla A, et al. Among authors: candon s. Transplantation. 2010 Dec 15;90(11):1180-4. doi: 10.1097/TP.0b013e3181fa941b. Transplantation. 2010. PMID: 20885337

10

Long-term CD4 lymphopenia is associated with accelerated decline of kidney allograft function.

Luque Y, Jamme M, Rabant M, DeWolf S, Noël LH, Thervet E, Chatenoud L, Snanoudj R, Anglicheau D, Legendre C, Candon S, Zuber J. Luque Y, et al. Among authors: candon s. Nephrol Dial Transplant. 2016 Mar;31(3):487-95. doi: 10.1093/ndt/gfv362. Epub 2015 Oct 22. Nephrol Dial Transplant. 2016. PMID: 26492923

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69 results

Search Page